Skip to main content

Advertisement

SpringerLink
Log in

Analysis of risk factors for progressive fibrovascular proliferation in proliferative diabetic retinopathy

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the risk factors associated with progressive fibrovascular proliferation (FVP) in proliferative diabetic retinopathy (PDR).

Methods

We retrospectively reviewed the clinical data of patients who underwent pars plana vitrectomy for PDR between August 2017 and October 2019 at our department of ophthalmology. The FVP was divided into five grades based on the coverage area of proliferative membrane. Then we compared the patients with different severities of FVP to analyze the risk factors for higher grade of FVP in PDR.

Results

Univariate analysis showed that positive urinary protein (p = 0.007), higher levels of serum blood urea nitrogen (BUN) (p < 0.001) and serum creatinine (p < 0.001), more severe stage of estimated glomerular filtration rate (p < 0.001), age < 45 years (p = 0.005), longer duration of diabetic retinopathy (p = 0.007), history of hypertension (p = 0.034) and smoking (p = 0.008) were related to FVP grade ≥ 3. Multivariate analysis showed that the level of BUN, age < 45 years and smoking were independent risk factors for FVP grade ≥ 3 in PDR patients.

Conclusion

This study demonstrated that BUN (odds ratio [OR] = 1.318, 95% confidence interval [CI] = 1.150–1.511, p < 0.001), age ≤ 45 years (OR = 3.774, 95% CI = 1.762–8.082, p = 0.001) and smoking (OR = 2.111, 95% CI = 1.040–4.288, p = 0.039) were independent risk factors for progressive FVP in PDR among northeastern Chinese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Thomas R, Halim S, Gurudas S, Sivaprasad S, Owens D (2019) IDF Diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract 157:107840. https://doi.org/10.1016/j.diabres.2019.107840

    Article  CAS  PubMed  Google Scholar 

  2. Jia W (2014) Diabetes: a challenge for China in the 21st century. Lancet Diabetes Endocrinol 2(4):e6–7. https://doi.org/10.1016/s2213-8587(14)70027-0

    Article  PubMed  Google Scholar 

  3. Fong DS, Aiello L, Gardner TW, King GL, Klein R (2004) Retinopathy in diabetes. Diabetes Care 27(Supplement 1):S84–87. https://doi.org/10.2337/diacare.27.2007.S84

    Article  PubMed  Google Scholar 

  4. Tikkanen-Dolenc H, Wadén J, Forsblom C, Harjutsalo V, Thorn L, Saraheimo M, Elonen N, Hietala K, Summanen P, Tikkanen H, Groop P (2019) Frequent physical activity is associated with reduced risk of severe diabetic retinopathy in type 1 diabetes. Acta Diabetol. https://doi.org/10.1007/s00592-019-01454-y

    Article  PubMed  PubMed Central  Google Scholar 

  5. Grunwald J, Pistilli M, Ying G, Daniel E, Maguire M, Xie D, Roy J, Whittock-Martin R, Parker Ostroff C, Lo J, Townsend R, Gadegbeku C, Lash J, Fink J, Rahman M, Feldman H, Kusek J (2019) Association between progression of retinopathy and concurrent progression of kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study. JAMA Ophthalmol 137(7):767–774. https://doi.org/10.1001/jamaophthalmol.2019.1052

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rosa L, Zajdenverg L, Souto D, Dantas J, Pinto M, Salles G, Rodacki M (2019) HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background. J Diabetes Complicat 33(9):610–615. https://doi.org/10.1016/j.jdiacomp.2019.05.022

    Article  PubMed  Google Scholar 

  7. Song P, Yu J, Chan K, Theodoratou E, Rudan I (2018) Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health 8(1):010803. https://doi.org/10.7189/jogh.08.010803

    Article  PubMed  PubMed Central  Google Scholar 

  8. Levey A, Stevens L, Schmid C, Zhang Y, Castro A, Feldman H, Kusek J, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612

    Article  Google Scholar 

  9. Gibbons A, Leung E, Haddock L, Medina C, Fernandez V, Parel J, Durkee H, Amescua G, Alfonso E, Perez V (2018) Long-term outcomes of the aphakic snap-on Boston type I keratoprosthesis at the Bascom Palmer Eye Institute. Clin Ophthal 12:331–337. https://doi.org/10.2147/OPTH.S144403

    Article  Google Scholar 

  10. Huang C, Hsieh Y, Yang C (2017) Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes. Graefe's Arch Clin Experim Ophthal 255(5):863–871. https://doi.org/10.1007/s00417-016-3579-4

    Article  Google Scholar 

  11. Zhuang X, Cao D, Yang D, Zeng Y, Yu H, Wang J, Kuang J, Xie J, Zhang S, Zhang L (2019) Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study. BMJ Open 9(9):e031194. https://doi.org/10.1136/bmjopen-2019-031194

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hsieh Y, Tsai M, Tu S, Hsieh M (2018) Association of abnormal renal profiles and proliferative diabetic retinopathy and diabetic macular edema in an asian population with type 2 diabetes. JAMA Ophthalmol 136(1):68–74. https://doi.org/10.1001/jamaophthalmol.2017.5202

    Article  PubMed  Google Scholar 

  13. Park H, Lee Y, Cho A, Han C, Noh J, Shin Y, Bae S, Kim H (2019) Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus. PLoS ONE 14(7):e0220506. https://doi.org/10.1371/journal.pone.0220506

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yamanouchi M, Mori M, Hoshino J, Kinowaki K, Fujii T, Ohashi K, Furuichi K, Wada T, Ubara Y (2019) Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease. BMJ Open Diabetes Res Care 7(1):e000726. https://doi.org/10.1136/bmjdrc-2019-000726

    Article  PubMed  PubMed Central  Google Scholar 

  15. Barrett E, Liu Z, Khamaisi M, King G, Klein R, Klein B, Hughes T, Craft S, Freedman B, Bowden D, Vinik A, Casellini C (2017) Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 102(12):4343–4410. https://doi.org/10.1210/jc.2017-01922

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zhang G, Chen H, Chen W, Zhang M (2017) Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol 101(12):1591–1595. https://doi.org/10.1136/bjophthalmol-2017-310316

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zhong Z, Han M, Chen S (2011) Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus. Int J Ophthalmol 4(2):182–185. https://doi.org/10.3980/j.issn.2222-3959.2011.02.15

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lee WJ, Sobrin L, Lee MJ, Kang MH, Seong M, Cho H (2014) The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3). Investig Ophthalmol Vis Sci 55(10):6547. https://doi.org/10.1167/iovs.14-15001

    Article  CAS  Google Scholar 

  19. Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, Moreno-Ribas A, Valls-Mateu A, Sagarra-Alamo R, Barrot-De La Puente J, Mundet-Tuduri X (2018) Glomerular filtration rate and/or ratio of urine albumin to creatinine as markers for diabetic retinopathy: a ten-year follow-up study. J Diabetes Res 2018:5637130. https://doi.org/10.1155/2018/5637130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bhalla V, Zhao B, Azar K, Wang E, Choi S, Wong E, Fortmann S, Palaniappan L (2013) Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care 36(5):1215–1221. https://doi.org/10.2337/dc12-0951

    Article  PubMed  PubMed Central  Google Scholar 

  21. Srivastav K, Saxena S, Mahdi A, Kruzliak P, Khanna V (2015) Increased serum urea and creatinine levels correlate with decreased retinal nerve fibre layer thickness in diabetic retinopathy. Biomarkers 20(6–7):1–4. https://doi.org/10.3109/1354750X.2015.1094142

    Article  CAS  Google Scholar 

  22. Hwang H, Chae J, Kim J, Moon B, Kim D (2019) Changes in optical coherence tomography findings in patients with chronic renal failure underagoing dialysis for the first time. Retina 39(12):2360–2368. https://doi.org/10.1097/IAE.0000000000002312

    Article  PubMed  Google Scholar 

  23. Wong J, Molyneaux L, Constantino M, Twigg S, Yue D (2008) Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 31(10):1985–1990. https://doi.org/10.2337/dc08-0580

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lim M, Lee S, Cheng B, Wong D, Ong S, Ang C, Yeo I (2008) Diabetic retinopathy in diabetics referred to a tertiary centre from a nationwide screening programme. Ann Acad Med Singapore 37(9):753–759. https://doi.org/10.1097/MAJ.0b013e31815b9d51

    Article  PubMed  Google Scholar 

  25. Klein R, Klein B, Moss S, Davis M, DeMets D (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102(4):527–532. https://doi.org/10.1016/S0161-6420(89),32699-6

    Article  CAS  PubMed  Google Scholar 

  26. Bressler S, Beaulieu W, Glassman A, Gross J, Melia M, Chen E, Pavlica M, Jampol L (2019) Photocoagulation versus ranibizumab for proliferative diabetic retinopathy: should baseline characteristics affect choice of treatment? Retina 39(9):1646–1654. https://doi.org/10.1097/iae.0000000000002377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mohamed Q, Gillies M, Wong T (2007) Management of diabetic retinopathy: a systematic review. JAMA 298(8):902–916. https://doi.org/10.1001/jama.298.8.902

    Article  CAS  Google Scholar 

  28. Biesenbach G, Grafinger P, Janko O, Zazgornik J (1997) Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 48(3):146–150. https://doi.org/10.1016/j.jcrs.2006.07.048

    Article  CAS  PubMed  Google Scholar 

  29. Chiolero A, Faeh D, Paccaud F, Cornuz J (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87(4):801–809. https://doi.org/10.1093/ajcn/87.4.801

    Article  CAS  PubMed  Google Scholar 

  30. Costa F, Soares R (2009) Nicotine: a pro-angiogenic factor. Life Sci 84(23–24):785–790. https://doi.org/10.1016/j.lfs.2009.03.002

    Article  CAS  PubMed  Google Scholar 

  31. Mühlhauser I, Bender R, Bott U, Jörgens V, Grüsser M, Wagener W, Overmann H, Berger M (1996) Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabetic Med J Br Diabetic Assoc 13(6):536–543. https://doi.org/10.1002/(sici)1096-9136(199606)13:6%3c536:aid-dia110%3e3.0.co;2-j

    Article  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Second Hospital of Jilin University, Jilin University, No. 218, ChangChun, Ziqiang Street, Changchun, 130041, People’s Republic of China

    Yu-Bo Wu, Chen-Guang Wang, Ling-Xian Xu, Chen Chen, Xue-Bin Zhou & Guan-Fang Su

Authors
  1. Yu-Bo Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen-Guang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ling-Xian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xue-Bin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guan-Fang Su
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guan-Fang Su.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants or parents/guardians included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, YB., Wang, CG., Xu, LX. et al. Analysis of risk factors for progressive fibrovascular proliferation in proliferative diabetic retinopathy. Int Ophthalmol 40, 2495–2502 (2020). https://doi.org/10.1007/s10792-020-01428-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-020-01428-y

Keywords

Search

Navigation